Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DI5V7K
|
|||
| Drug Name |
V184
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Chikungunya virus infection [ICD-11: 1D40; ICD-9: 001-139, 042-075] | Phase 2 | [1] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03807843) Phase 2 Study of a Live Attenuated Measles Virus-Vectored Chikungunya Vaccine in Previously Exposed Adults. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.